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Stent graft repair of aortic pathology involving the distal aortic arch requires precise device deployment based on excellent
imaging and stable hemodynamics. An inadequate proximal seal may result in a type I endoleak, which may require an
additional device or even conversion to open surgery to control. This case report describes transvenous rapid pacing, a safe
and reproducible technique to allow precise deployment or balloon dilation of a stent graft in the distal arch or proximal
thoracic aorta. ( J Vasc Surg 2008;47:629-31.)Endovascular techniques are being increasingly applied
to the thoracic aorta for thoracic aneurysms, pseudoaneu-
rysm, and more complex pathologies such as post-trau-
matic aortic rupture and complicated type B dissections.1-4
Despite increasing expertise and experience in deploying
stent grafts in the thoracic aorta, the technical challenges of
deploying these devices in a highly angulated aortic arch are
formidable.
Accurate deployment depends on excellent imaging
and stable hemodynamics (Fig 1 and 2). This is of utmost
importance during postdeployment ballooning to aid in
approximation of the stent graft against the aortic wall.
Traditionally, the blood pressure is lowered pharmacolog-
ically using various vasodilators in concert with -block-
ers.5,6 When additional hemodynamic control is required,
adenosine (6- to 12-mg intravenous bolus) has been used
to create a temporary state of asystole. The negative chro-
notropic effect generally lasts less than 10 seconds, with
subsequent return of rhythm. However, there is uncer-
tainty of duration, dose, and reproducibility of asystole, as
well as the possibility of inadequate return of rhythm. This
has prompted us to use rapid ventricular pacing to tempo-
rarily abolish ejection forces during graft deployment and
ballooning in the ascending aorta, arch, and proximal de-
scending aorta. We describe the technique of temporary
transvenous right ventricular pacing to allow accurate con-
trol of cardiac output and hemodynamics to facilitate accu-
rate deployment of stent grafts in the proximal aorta with
three representative indications.
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Endovascular procedures are performed after anticoag-
ulation to achieve an activated clotting time 250 seconds.
A 6F sheath is introduced into the femoral vein, and a
dual-lead pacing wire is maneuvered through this under
fluoroscopic guidance into the apex of the right ventricle
until ventricular capture is obtained (Fig 2) The patient is
test-paced at a rate of 180 beats/min, and the electrocar-
diogram and arterial waveform are examined to confirm
adequate capture and a cessation of ventricular ejection. If
ventricular ejection persists at this rate, the pacer rate is
increased in 20-beats/min increments until ejection is
abolished. If one-to-one capture is not obtained at higher
rates, the rate is decreased in 5- to 10-beats/min incre-
ments until capture is achieved.
Pacing is commenced immediately before graft deploy-
ment or ballooning and is stopped immediately after the
maneuver. The heart is allowed to return to its normal
underlying rhythm. This process is repeated as often as
necessary to achieve adequate expansion of the stent graft.
When deployment is completed, the pacer wire and sheath
are withdrawn, and hemostasis is achieved with direct pres-
sure.
CASE REPORTS
Patient 1. A 62-year-old man with a history of an aneurysm
involving the distal aortic arch and proximal descending thoracic
aorta demonstrated rapid growth from 4.5 cm to 5.4 cm on
computed tomography (CT) scans 6 months apart. He underwent
left common carotid–left subclavian artery bypass with an 8-mm
polytetrafluoroethylene (PTFE) interposition graft the previous
day.
Under general anesthesia and orotracheal intubation, the right
femoral artery was accessed through an oblique incision, and a
Lunderquist wire (Cook, Bloomington, Ind) was placed into the
ascending aorta by using an exchange technique. Arch aortography
was performed through the left brachial artery and traversing the
carotid–subclavian bypass. This demonstrated the brachiocephalic
vessels and aneurysm.
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staff, Ariz) was delivered just distal to the left common carotid
origin through the right common femoral artery. A type I endoleak
was noted, and a decision was made to balloon the proximal
Fig 1. Intraoperative angiogram demonstrates a proximal en-
doleak after deployment and ballooning of a 34-mm  15-cm
TAG (W.L. Gore & Assoc, Flagstaff, Ariz) device (large arrow).
Note the lack of optimal apposition of the proximal end of the
device (small arrow). When the stent graft was ballooned, it
migrated distally despite a significant reduction in blood pressure
pharmacologically.
Fig 2. Intraoperative angiography of the same patient after place-
ment and ballooning with rapid ventricular pacing of a second
stent graft (large black arrow). Completion angiography shows no
endoleak. A dual-lead right ventricular pacing wire (small black
arrow) is shown crossing the tricuspid valve (white arrow).portion of the stent graft. Despite pharmacologically lowering thesystolic blood pressure to 60 mm Hg, the device migrated distally
during brief inflation of a CODA balloon (Cook). A second TAG
device, measuring 34 mm 10 cm, was delivered just distal to the
left common carotid artery. Although properly positioned, the
device was not fully opposed to the aorta.
During the second round of ballooning, rapid right ventricu-
lar pacing was used. After capture and cessation of ventricular
ejection at a rate of 180 beats/min, profile ballooning of the stent
graft was performed without incident, and an excellent angio-
graphic result was obtained. Coils were inserted in the left subcla-
vian artery origin to treat a type II endoleak. The patient tolerated
the procedure well and was transferred to intensive care for recov-
ery. Follow-up CT imaging demonstrates no evidence of type I
endoleak.
Patient 2. A 69-year-old woman lost to follow-up 30 years
after open repair of a traumatic aortic transection presented with
acute congestive heart failure and acute renal failure due to severe
coarctation of the aorta at the site of her previous repair. She was
optimized medically and renal function recovered. The patient was
offered endovascular repair of her coarctation and consented to
proceed.
Under general anesthesia, vascular access was obtained
through the right brachial artery and heparin was given. A floppy
Glidewire (Terumo Medical Corp, Somerset, NJ) was directed
across the coarctation into the right femoral artery, and through-
and-through wire access was obtained. The right brachial sheath
was exchanged for a 55-cm 5F sheath, and the wire was exchanged
for a 300-cm Amplatz wire (Boston Scientific, Natick, Mass). The
coarctation was predilated with a 10-mm  4-cm balloon. A
28-mm  10-cm TAG device was then delivered across the lesion
through the femoral artery. The device was dilated with a 32-mm
CODA balloon, but the coarctation was still tight. It was then
further dilated with a Palmaz stent (Cordis, Miami Lakes, Fla)
delivered on a 25-mm Tyshak (B. Braun, Bethlehem, Pa) balloon.
Right ventricular transvenous pacing at a rate of 200 beats/
min through the left femoral vein was used to allow accurate
positioning and deployment of the Palmaz stent. Because of the
tenacity of the stricture, it was postdilated, which required the use
of multiple balloons. Proximal and distal coarctation pressures
were measured, and there was no gradient across the lesion.
Follow-up examination and CT imaging demonstrated no further
clinical symptoms, normal ankle-brachial indices, and an intact
repair.
Patient 3. A 66-year-old man was transferred to our facility
with a ruptured thoracic aneurysm presenting as acute hoarseness.
He was brought to the operating room. Under general anesthesia,
the right femoral artery was exposed and the ascending aorta
accessed after heparinization. Arch angiography performed
through a left femoral percutaneous access demonstrated extrava-
sation of contrast in the region of the aortic isthmus. A 34-mm 
15-cm TAG stent graft was deployed just distal to the left carotid
artery. Completion angiography revealed exclusion of the aneu-
rysm with no evidence of endoleak. The patient arrived at the
intensive care unit in stable condition.
A CT on postoperative day 2 demonstrated an endoleak in the
middle portion of the stent graft. The exact origin was unclear, and
a type I leak had to be ruled out.
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arterial access was obtained. Although the endoleak was not visu-
alized angiographically, the decision was made to balloon the
proximal portion of the stent graft. Percutaneous transvenous right
ventricular pacing at a rate of 175 beats/min was used to allow safe
ballooning of the stent graft and to minimize the risk of device
migration in a potentially unstable aorta. Repeat angiography
confirmed a well-placed device and no evidence of endoleaks.
Subsequent CT imaging at the 1-month follow-up revealed reso-
lution of the endoleak and a well-positioned stent graft.
DISCUSSION
An increasing wealth of evidence supports endovascular
management of thoracic aortic pathology, including aneu-
rysms, traumatic rupture, and complicated type B dissec-
tions.2-4,7,8 As further experience has been gained, more
complex aortic pathology has been treated using stent
grafts, with the proximal extent of the pathology moving
from the descending aorta into the aortic arch and even the
ascending aorta. As stent grafts are deployed closer to the
aortic valve, forces exerted on the devices and balloons
increase.
Thoracic stent graft manufacturers have addressed this
issue in various ways. The Gore TAG device deploys from
the middle outwards, and the Medtronic Talent and Cook
TX2 devices are sequentially unsheathed and can be repo-
sitioned before final release from the delivery system. These
adaptations of the various delivery systems have provided
for fairly accurate delivery of these devices, but all of them
frequently require additional ballooning to optimize seal-
ing and conformation to the aortic wall. This is especially
true in the tortuous anatomy of the arch, where the force of
blood flow against the inflated balloon may result in distal
movement of the graft. The Gore trilobed balloon was
designed to reduce this risk, but we have found it is still
vulnerable to the severe hemodynamic forces in the more
proximal aorta. Other profiling balloons provide excellent
circumferential displacement and are quick to inflate and
deflate, but migration is still an issue. Although adenosine is
commonly used to counteract this problem, the transient
nature of asystole cannot be controlled, and an ill-timed
resumption of ventricular contraction may result in distal
migration and a compromised result.
Induced ventricular fibrillation is frequently used dur-
ing cardiac surgery, and the technique is relatively simple,
with little risk. Although our experience with this strategy is
limited during thoracic aortic stent grafting, it has been
commonly used in hundreds of balloon aortic valvuloplas-
ties and percutaneous aortic valve replacements without
negative cardiovascular consequences.9,10 This technique is
remarkably well-tolerated, even in this high-risk population
being treated for critical aortic stenosis and at prohibitive
risk for conventional surgery. In the unlikely event that apatient does not spontaneously recover cardiac output
when the rapid pacing is stopped, cardioversion and tem-
porary pacing may be initiated until complete cardiac re-
covery is achieved. Potential complications of this tech-
nique are more related to venous access and positioning the
pacemaker wire within the right ventricle. Care must be
taken to avoid right ventricular perforation secondary to
forceful manipulation.
Although this technique is helpful in assuring accurate
deployment of devices in a limited seal zone, the fundamen-
tal principle of sealing in healthy aorta over an adequate
length must not be compromised.
CONCLUSION
The technique of transvenous rapid pacing of the right
ventricle to achieve hypotension and cessation of ventricu-
lar ejection is safe and reproducible and should be consid-
ered as an alternative to pharmacologic hemodynamic con-
trol whenever balloon dilation of a stent graft in the distal
arch or more proximal aorta is required—when precise
stent graft deployment is of paramount importance.
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